rs6454674 — CNR1 Near gene (SNP3)

The Third CNR1 Locus — An Independent Genetic Switch for Substance Dependence

The CNR1 gene encodes CB1¹¹ CB1
Cannabinoid receptor type 1 — the most abundant G-protein-coupled receptor in the brain, expressed densely in the prefrontal cortex, hippocampus, amygdala, and basal ganglia. CB1 is the primary target for the brain's own endocannabinoids (anandamide and 2-AG) and for the psychoactive component of cannabis, THC, the master regulator of endocannabinoid signaling across the brain's reward and emotion circuits. Two CNR1 variants — rs806368 and rs1049353 — are already well characterized as a tight haplotype block that modulates CB1 receptor expression and shapes vulnerability to cannabis-related brain changes. Rs6454674 tells a different story: it sits in a completely separate region of the CNR1 gene, captures independent genetic variation, and exerts its most significant effects not alone, but in combination with rs806368 — producing synergistic substance dependence risk that neither variant generates individually.

The Mechanism

Rs6454674 lies within an intron of CNR1 at chromosome 6 position 88,163,211 (GRCh38). The CNR1 gene is on the minus strand, and the plus-strand alleles — T (reference) and G (alternate) — are therefore the complement of the coding-strand orientation used in some older publications. The variant's intronic location means it does not change the CB1 protein sequence directly. Its functional mechanism remains to be fully characterized, but the most likely explanation is a regulatory role: intronic variants can affect mRNA splicing, create or disrupt transcription factor binding sites within intronic enhancers, or influence alternative transcript production. The CNR1 locus produces multiple transcript isoforms with distinct functional properties, and regulatory variants within introns have documented effects on CNR1 expression in postmortem brain tissue.

Critically, rs6454674 and rs806368 sit in entirely separate linkage disequilibrium²² linkage disequilibrium
LD — a statistical term describing the non-random association of alleles at nearby loci. High LD means the variants are inherited together and tag the same underlying mutation; low LD means they are inherited independently and capture distinct genetic signals blocks within the CNR1 region. Nomura et al. 2009³³ Nomura et al. 2009
Nomura A et al. Interaction between two independent CNR1 variants increases risk for cocaine dependence in European Americans. Neuropsychopharmacology, 2009 formally measured the LD between them: D' = 0.026, r² = 0. These are the statistics of complete independence — the two variants are essentially uncorrelated. This independence is what makes their combination scientifically interesting: two separate regulatory variants in the same gene, each capturing different aspects of CB1 biology, produce a synergistic effect on addiction risk that exceeds what either contributes alone.

The Evidence

Drug and alcohol dependence — the original finding. The first evidence for rs6454674 came from Zuo et al. 2007⁴⁴ Zuo et al. 2007
Zuo L et al. CNR1 variation modulates risk for drug and alcohol dependence. Biol Psychiatry, 2007, a study of 1,001 European- and African-American individuals assessed for drug dependence (DD) and alcohol dependence (AD). The G allele at rs6454674 showed a dose-response relationship with substance dependence subtypes: risk increased with each additional copy of the G allele. More strikingly, when the interaction between rs6454674(G+) and rs806368(T/T) was tested, it produced p = 0.0002 for drug dependence alone — a near three-order-of-magnitude improvement over either SNP's individual effect. The combined p-value for comorbid drug and alcohol dependence was 0.0003; for alcohol dependence alone, 0.007. This interaction signal was the strongest finding in the entire CNR1 locus scan and established these two independent regulatory variants as a functionally cooperative pair.

Cocaine dependence — replication and LD confirmation. Nomura et al. 2009⁵⁵ Nomura et al. 2009
Nomura A et al. Interaction between two independent CNR1 variants increases risk for cocaine dependence in European Americans. Neuropsychopharmacology, 2009 replicated the interaction in four independent cocaine dependence samples: European-American family-based (p = 0.015), European-American case-control (p = 0.003), African-American family-based, and African-American case-control. This study also provided the formal LD measurement (D' = 0.026, r² = 0) between rs6454674 and rs806368, and described three distinct haplotype blocks across the 45 kb CNR1 region — rs806368 in one block, rs6454674 in a separate block — confirming that the interaction reflects true genetic independence rather than statistical noise from correlated alleles.

Cocaine dependence — further replication. Gelernter et al. 2011⁶⁶ Gelernter et al. 2011
Gelernter J et al. Further evidence for association between genetic variants in the cannabinoid receptor 1 (CNR1) gene and cocaine dependence. Addict Biol, 2011 examined 883 cocaine-dependent cases and 334 controls of African descent. The GG homozygous genotype at rs6454674 was more common in cocaine-dependent cases (minor allele frequency 0.13 in cases vs. 0.08 in controls), and in a recessive model the association reached p = 0.017 independently. When combined with prior study data in meta-analysis, the G allele reached p = 0.004.

Alcohol dependence haplotypes. Marcos et al. 2012⁷⁷ Marcos et al. 2012
Marcos M et al. Cannabinoid receptor 1 gene is associated with alcohol dependence. Alcohol Clin Exp Res, 2012 in 298 male alcoholics found that a GGT haplotype spanning rs6454674(G), rs1049353(G), and rs806368(T) was significantly overrepresented in alcohol-dependent individuals (p = 0.006), and that the rs6454674 G allele interacted with the rs806368 C allele at p = 0.009.

Schizophrenia symptom severity. A Turkish study (Copoglu et al. 2015, n = 66 patients, 65 controls; published in Klinik Psikofarmakol Bülteni — not PMID-indexed) found no difference in rs6454674 allele frequencies between schizophrenia patients and healthy controls, but found that patients carrying the G allele at rs6454674 had significantly lower PANSS total, PANSS positive, PANSS negative, PANSS general psychopathology, and CGI-S scores than patients without the polymorphism. This observation — the G allele conferring both increased substance dependence risk and attenuated schizophrenia severity — is biologically intriguing but based on a small sample from a single center and should be considered emerging evidence only. The endocannabinoid system is known to participate in both domains, and altered CB1 expression or signaling could plausibly affect psychotic symptom expression independently of susceptibility.

Practical Implications

Rs6454674's primary clinical relevance is as an independent contributor to the endocannabinoid genetic risk architecture for substance dependence. At ~10% GG frequency globally, a meaningful fraction of the population carries two copies of the risk allele. The interaction data place this variant's importance in context: carrying both the rs6454674 G allele and the rs806368 TT genotype — which occur together in approximately 6–8% of Europeans and African Americans — produces the highest documented CNR1 genetic risk for drug dependence.

Because rs6454674 captures variation in a completely different regulatory region of CNR1 from the rs806368/rs1049353 haplotype, it provides genuinely additive information. Testing rs6454674 alongside the established haplotype block gives a more complete picture of the CNR1 risk architecture than either marker set alone.

Interactions

Rs6454674 and rs806368 are the two CNR1 variants with the strongest documented gene-gene interaction for substance dependence (Zuo 2007; Nomura 2009). Their independence is proven: D' = 0.026, r² = 0. The rs806368/rs1049353 haplotype block (D' = 0.95 between those two) represents one molecular signal; rs6454674 represents a second, independent signal from a different part of the same gene. Combined carriers of rs6454674(G+) and rs806368(TT) face the steepest CNR1 genetic slope toward drug and alcohol dependence documented in the literature. See also: the FAAH gene (rs324420), which controls anandamide breakdown and has been studied for interactive effects with CNR1 variants in cannabis cue reactivity and stress-response contexts.